This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,506.68, is for the delivery of Irbesartan 300 mg tablets to support military healthcare programs. The contract has a completion date of January 8, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,432.74, is for the delivery of Irbesartan 300 mg tablets. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $11,048.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg tablets, a medication used to treat high blood pressure. The contract is a Firm Fixed Price Delivery Order with a completion date of January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Irbesartan 300 mg tablets to the Defense Logistics Agency (DLA). The $2,564.06 firm fixed-price delivery order has a completion date of February 11, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,194.28 firm-fixed-price contract is for the supply of 150 mg Irbesartan tablets in 90-count bottles. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen is a significant supplier of pharmaceutical and medical products to various federal agencies and healthcare programs. Through its...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The delivery order, valued at $2,697.68, is for the supply of Irbesartan 150 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of June 25, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This federal contract award, valued at $3,637.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order worth $2,387.56 for the supply of Irbesartan 300 mg tablets. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.89 firm fixed-price delivery order is for the supply of Irbesartan 150 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with...
This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH7JY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Irbesartan 150 mg tablets, a cardiovascular medication, with a total ceiling value of $6,617.42 and a completion date of December 4, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...